HSP90aa1 upregulates both mRNA and protein levels of BCL6 in vitro, and HSP90 inhibition can induce antitumour effects in BCL6 positive DLBCL mouse models [26]. Here, BCL6 is linked to diffuse large B-cell lymphoma.